Markets:

Overview

News

Currencies

International

Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

9.190 -0.040 (-0.43%)

Delayed Quote Updated: 1:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 12, 2022

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Recap: Tonix Pharmaceuticals Q3 Earnings ↗

November 07, 2022

Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News ↗

August 01, 2022

While Tonix Pharmaceuticals has been embattled this year, a critical patent issuance for one of its drugs has bolstered TNXP stock.

Via InvestorPlace

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗

November 03, 2022

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...

Via Benzinga

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll...

Via PressReach

Topics Cannabis

Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

October 05, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

Via FinancialNewsMedia

Topics Cannabis

New Ways To Treat Long Covid Might Be Here Sooner Than Thought ↗

September 20, 2022

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Psychedelics Use Among Young Adults Reaches All-Time High

September 01, 2022

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever. According to a National Institute of Health survey,...

Via FinancialNewsMedia

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗

August 26, 2022

Via Benzinga

Looking Into Tonix Pharmaceuticals's Recent Short Interest ↗

August 23, 2022

Tonix Pharmaceuticals's (NASDAQ:TNXP) short percent of float has risen 204.49% since its last report. The company recently reported that it has 2.36 million shares sold short,...

Via Benzinga

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗

August 23, 2022

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.

Via Benzinga

Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗

August 22, 2022

Via Benzinga

Tonix Pharmaceuticals Commences Mid-Stage Long COVID Study, Sees Interim Report In H1 2023 ↗

August 22, 2022

Tonix Pharmaceuticals (NASDAQ: TNXP) has initiated patient enrolment in the Phase 2 PREVAIL study of TNX-102 SL for patients with Long COVID syndrome (Long COVID).

Via Benzinga

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗

August 19, 2022

Via Benzinga

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗

August 18, 2022

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.

Via Benzinga

WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant ↗

August 18, 2022

Via Benzinga

A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring ↗

August 17, 2022

Blue Water Vaccines Inc (NASDAQ: BWV)

Via Benzinga

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗

August 17, 2022

Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide,

Via Benzinga

WeTrade's Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits? ↗

August 16, 2022

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak ↗

August 01, 2022

The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care...

Via Benzinga

Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗

August 02, 2022

Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.

Via Benzinga

This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗

August 01, 2022

Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.

Via Benzinga

Why Tonix Pharmaceuticals Stock Is Rising ↗

August 01, 2022

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Monday after New York City on Saturday declared monkeypox a public health emergency, which has lifted monkeypox-related...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 01, 2022

Via Benzinga

Why Celyad Oncology Is Trading Higher By Over 31%; Here Are 29 Stocks Moving Premarket ↗

August 01, 2022

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The company agreed to initially offer 2.00 million shares to the public at a $5.00...

Via Benzinga

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate ↗

July 28, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

The Newspapers of New England Family

We continue to need local support from our readers

HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

Enjoying the Concord Monitor?

Sign in